EUVIMEDEUVIMED entdecken
Umbrella Review

L26/P-141 An umbrella review of RCT-based systematic reviews comparing blastocyst versus cleavage-stage embryo transfer

L.H. Sordia-Hernandez, F.A. Morales Martinez, M.O. Sordia Piñeyro, J. Palau Torre, S.M. Garcia Luna, A. Morales Leal, L.H. Sordia Piñeyro, J.A. Alipi García, A.C. Guajardo Aldaco, D. Morales Gutierrez, O.H. Valdes Martínez, C. Ramirez Colunga

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.477 ↗

Kurz gefasst

Umbrella Review in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von L.H. Sordia-Hernandez und 11 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Do the higher live birth rates associated with blastocyst transfer justify a universal blastocyst-only embryo transfer policy? Summary answer Although blastocyst transfer improves live birth rates, it significantly increases cancellation without reducing miscarriage or multiple pregnancy rates, questioning universal blastocyst-only transfer policies. What is known already Improved live birth rates have been reported after blastocyst transfer. The use of better culture media, among other technological innovations, as well as concerns about multiple pregnancies and higher miscarriage rates, have favored policies of transferring only blastocyst-stage embryos. However, prolonged culture can increase the number of women without embryos available for transfer. Furthermore, several reports question whether blastocyst transfer is associated with a lower number of multiple pregnancies. There are also concerns about the quality of the evidence supporting this practice, so this policy of transferring only blastocysts should be thoroughly reviewed. Study design, size, duration Following PRISMA guidelines, this umbrella review was conducted from March to December 2024. A total of 1,288 studies were screened, of which five systematic reviews of RCTs were ultimately included. These reviews encompassed publications from 2000 to 2018, with search strategies executed between 2007 and 2021. The included reviews contained between 5 and 32 individual RCTs, with sample sizes ranging from 1,446 to 5,821 participants. Participants/materials, setting, methods This umbrella review and meta-analysis followed PRISMA guidelines. A systematic search of PubMed, Medline, Embase, and Web of Science identified systematic reviews and meta-analyses comparing blastocyst versus cleavage-stage embryo transfer outcomes. Five systematic reviews of RCTs, including 13,123 participants, met inclusion criteria. Data were extracted and pooled for quantitative synthesis through forest plots. Methodological quality was rigorously assessed using the AMSTAR 2 critical apprasial tool. Main results and the role of chance Pooled analysis showed that blastocyst transfer was associated with significantly higher live birth rates (OR 1.42; 95% CI 1.19–1.70), clinical pregnancy rates (OR 1.29; 95% CI 1.20–1.39), implantation rates (OR 1.38; 95% CI 1.09–1.74), and ongoing pregnancy rates (OR 1.69; 95% CI 1.07–2.65) compared with cleavage-stage embryo transfer. No significant differences were observed between groups in cumulative pregnancy rate (OR 0.82; 95% CI 0.65–1.03), miscarriage rate (OR 0.94; 95% CI 0.66–1.34), multiple pregnancy rate (OR 1.03; 95% CI 0.87–1.23), or ectopic pregnancy rate (OR 0.73; 95% CI 0.27–2.00). Importantly, blastocyst transfer was associated with a significantly higher cancellation rate (OR 2.36; 95% CI 1.81–3.09). Limitations, reasons for caution Quality assessment using the AMSTAR 2 tool revealed heterogeneity in methodological rigor among the included studies. While three systematic reviews demonstrated high methodological quality, two were rated as critically low quality. This methodological variability represents an important limitation and warrants cautious interpretation of the overall findings. Wider implications of the findings While blastocyst transfer significantly increases live birth rates, this must be weighed against higher cycle cancellation risks. The expected reduction in multiple pregnancies was not confirmed. These findings challenge universal blastocyst-only policies and support individualized embryo transfer timing based on patient-specific factors. Trial registration number Yes

Zitieren

APA

Sordia-Hernandez, L., Martinez, F. M., Piñeyro, M. S., Torre, J. P., Luna, S. G., Leal, A. M., Piñeyro, L. S., García, J. A., Aldaco, A. G., Gutierrez, D. M., Martínez, O. V., & Colunga, C. R. (2026). L26/P-141 An umbrella review of RCT-based systematic reviews comparing blastocyst versus cleavage-stage embryo transfer. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.477

Vancouver

Sordia-Hernandez L, Martinez FM, Piñeyro MS, Torre JP, Luna SG, Leal AM, et al. L26/P-141 An umbrella review of RCT-based systematic reviews comparing blastocyst versus cleavage-stage embryo transfer. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.477

BibTeX
@article{SordiaHernandez2026,
  author = {Sordia-Hernandez, L.H. and Martinez, F.A. Morales and Piñeyro, M.O. Sordia and Torre, J. Palau and Luna, S.M. Garcia and Leal, A. Morales and Piñeyro, L.H. Sordia and García, J.A. Alipi and Aldaco, A.C. Guajardo and Gutierrez, D. Morales and Martínez, O.H. Valdes and Colunga, C. Ramirez},
  title = {L26/P-141 An umbrella review of RCT-based systematic reviews comparing blastocyst versus cleavage-stage embryo transfer},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.477}
}
Kostenlos starten →